
### [MONDO:0016518](http://purl.obolibrary.org/obo/MONDO_0016518)
**Label:** isolated punctate palmoplantar keratoderma

**Subclasses:** [MONDO:0017676](http://purl.obolibrary.org/obo/MONDO_0017676) (marginal papular palmoplantar keratoderma), [MONDO:0019332](http://purl.obolibrary.org/obo/MONDO_0019332) (punctate palmoplantar keratoderma type 1), 

**Corr. equiv. classes:** [Orphanet:79501](http://www.orpha.net/ORDO/Orphanet_79501), [Orphanet:307995](http://www.orpha.net/ORDO/Orphanet_307995), 

**Class expressions from DL-Learner:**

- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and [HP:0100273](http://purl.obolibrary.org/obo/HP_0100273) (Neoplasm of the colon) 75.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 75.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 75.00%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) 75.00%
- [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) 75.00%
- [HP:0002894](http://purl.obolibrary.org/obo/HP_0002894) (Neoplasm of the pancreas) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) 75.00%
- [HP:0002862](http://purl.obolibrary.org/obo/HP_0002862) (Bladder carcinoma) and [HP:0100273](http://purl.obolibrary.org/obo/HP_0100273) (Neoplasm of the colon) 75.00%
- [HP:0002862](http://purl.obolibrary.org/obo/HP_0002862) (Bladder carcinoma) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 75.00%
- [HP:0002862](http://purl.obolibrary.org/obo/HP_0002862) (Bladder carcinoma) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 75.00%
- [HP:0002862](http://purl.obolibrary.org/obo/HP_0002862) (Bladder carcinoma) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 75.00%
- [HP:0002862](http://purl.obolibrary.org/obo/HP_0002862) (Bladder carcinoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) 75.00%
- [HP:0002862](http://purl.obolibrary.org/obo/HP_0002862) (Bladder carcinoma) and [HP:0002894](http://purl.obolibrary.org/obo/HP_0002894) (Neoplasm of the pancreas) 75.00%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) 75.00%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0002862](http://purl.obolibrary.org/obo/HP_0002862) (Bladder carcinoma) 75.00%
- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) 75.00%


